Revalor Xh Revalor Xs is a drug owned by INTERVET, INC. It is protected by 1 US drug patent filed in 2019. All patents have expired. Details of Revalor Xh Revalor Xs’s patents and their expiration are given below.
| Drug Patent Number | Drug Patent Expiry | Status |
|---|---|---|
 | ||
| USRE 39592 | Active | |
Exclusivity Information
Revalor Xh Revalor Xs holds 1 exclusivity out of which 1 has expired. Details of Revalor Xh Revalor Xs's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCI | Jan 19, 2010 |
About Revalor Xh Revalor Xs
Revalor Xh Revalor Xs is a drug
owned by INTERVET, INC.
Revalor Xh Revalor Xs uses
Estradiol, Trenbolone Acetate as the active
ingredients.
Active Ingredient:
Revalor Xh Revalor Xs uses
Estradiol,
Trenbolone Acetate
as the active ingredients.
Check out other Drugs and Companies using
Estradiol, Trenbolone Acetate ingredient.